Peptide receptor radionuclide therapy

This publication has 60 references indexed in Scilit:

• 213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
  Clinical Cancer Research, 2006
• Endocrine tumours of the pancreas
  Published by Elsevier ,2005
• Peptidrezeptorvermittelte Radiotherapie (PRRT) neuroendokriner Tumoren
  Der Onkologe, 2004
• Quality of Life in Patients With Gastroenteropancreatic Tumors Treated With [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate
  Journal of Clinical Oncology, 2004
• Assessment of Hepatic Toxicity from Treatment with ⁹⁰Y-SMT 487 (OctreoTher™) in Patients with Diffuse Somatostatin Receptor Positive Liver Metastases
  Cancer Biotherapy & Radiopharmaceuticals, 2003
• Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
  Seminars in Nuclear Medicine, 2002
• DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Cloning, Functional Expression and Pharmacological Characterization of a Fourth (hSSTR4) and a Fifth (hSSTR5) Human Somatostatin Receptor Subtype
  Biochemical and Biophysical Research Communications, 1993
• Somatostatin Receptors: Orphan That Found Family and Function
  Molecular and Cellular Neuroscience, 1993
• The stability in liver homogenates of indium-111 and yttrium-90 attached to antibody via two popular chelators
  Nuclear Medicine and Biology, 1993